GENFIT
Develops therapies and diagnostics for patients with rare and severe liver diseases.
GNFT | PA
Overview
Corporate Details
- ISIN(s):
- FR0004163111 (+2 more)
- LEI:
- 969500XPWN2DMZQA5X73
- Country:
- France
- Address:
- 885 AVENUE EUGENE AVINEE, 59120 LOOS
- Website:
- https://www.genfit.com
Description
GENFIT is a biopharmaceutical company dedicated to developing therapeutic and diagnostic solutions for patients with rare and severe liver diseases characterized by high unmet medical needs. The company's primary focus is on Acute-on-Chronic Liver Failure (ACLF) and its associated conditions, such as acute decompensation (AD) and hepatic encephalopathy (HE). Leveraging a scientific heritage of over two decades, GENFIT is a pioneer in liver disease research and development, aiming to improve the lives of patients with these life-threatening conditions.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2021-02-10 22:10 |
GENFIT annonce son calendrier financier pour 2021
|
French | 86.9 KB | ||
| 2021-02-09 22:10 |
GENFIT Announces Publication of Positive Results from the Phase 2 Clinical Tria…
|
English | 138.0 KB | ||
| 2021-02-09 22:10 |
GENFIT : publication des résultats positifs de l’essai clinique de Phase 2 éval…
|
French | 128.1 KB | ||
| 2021-01-28 22:10 |
GENFIT annonce la nomination de deux nouveaux membres au Comité Exécutif de la …
|
French | 122.1 KB | ||
| 2021-01-28 22:10 |
GENFIT Announces Two Key Appointments to the Executive Committee
|
English | 113.5 KB | ||
| 2021-01-27 21:30 |
GENFIT : Corrections techniques sur les votes de l’Assemblée des Porteurs du 25…
|
French | 108.4 KB | ||
| 2021-01-27 21:30 |
GENFIT: Technical Corrections to the Results of the January 25, 2021 Bondholder…
|
English | 99.0 KB | ||
| 2021-01-25 19:30 |
GENFIT : Franc succès de l’opération d’aménagement des termes et de rachat part…
|
French | 143.8 KB | ||
| 2021-01-25 19:30 |
GENFIT: Sweeping approval of OCEANEs buyback and amendments of terms
|
English | 125.5 KB | ||
| 2021-01-13 22:10 |
GENFIT annonce que son Assemblée Générale Extraordinaire sur seconde convocatio…
|
French | 193.0 KB | ||
| 2021-01-13 22:10 |
GENFIT announces that its Extraordinary General Meeting on second notice will b…
|
English | 132.8 KB | ||
| 2021-01-12 20:15 |
GENFIT : Assemblée Générale Extraordinaire du 13 janvier 2021 : Soutien largeme…
|
French | 168.5 KB | ||
| 2021-01-12 20:15 |
January 13, 2021 Extraordinary Shareholders Meeting: Wide support for the resol…
|
English | 146.0 KB | ||
| 2021-01-11 22:10 |
GENFIT : Bilan semestriel du contrat de liquidité contracté avec le Crédit Indu…
|
French | 268.9 KB | ||
| 2021-01-11 22:10 |
GENFIT: Half-Year Report of Liquidity Contract with Crédit Industriel et Comme…
|
English | 230.0 KB |
Automate Your Workflow. Get a real-time feed of all GENFIT filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for GENFIT
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for GENFIT via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2023-07-07 | N/A | Other | Buy | 5,300 | 19,488.10 EUR |
| 2023-07-06 | N/A | Other | Buy | 1,100 | 4,048.00 EUR |
| 2023-07-05 | N/A | Other | Buy | 10,000 | 37,061.00 EUR |
| 2023-07-03 | N/A | Other | Buy | 5,300 | 18,769.95 EUR |
Peer Companies
